Georg Greiner

14PUBLICATIONS
51CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Respiratory diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 24, 2023
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.

Georg Greiner, Nadine Witzeneder, Klara Klein

|Mar 15, 2023
Engraftment in NSG<sub>SCF</sub> mice correlates with the WHO category and prognosis in systemic mastocytosis.

Michael Willmann, Barbara Peter, Katharina Slavnitsch

|Feb 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik

|Jan 02, 2023
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.

Irene Graf, Georg Greiner, Rodrig Marculescu

|Jul 09, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in <i>KIT</i> D816V<sup>+</sup> Neoplastic Mast Cells.

Mathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl

|Jul 07, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemia.

Barbara Peter, Gregor Eisenwort, Irina Sadovnik

Pageof 3

Frequent Collaborators

8 joint publications

Peter Valent

5 joint publications

Gregor Hoermann

5 joint publications

Gregor Eisenwort

3 joint publications

Wolfgang R Sperr